Osaic Holdings’s Indivior Pharmaceuticals INDV Stock Holding History

Osaic Holdings’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	12,815 +3,359	+36%	+$122K	﹤0.01%	3630
2026 Q1	$288K	Sell	9,456 -24,541	-72%	-$810K	﹤0.01%	3836
2025 Q4	$1.22M	Buy	33,997 +33,887	+30,806%	+$1.03M	﹤0.01%	2502
2025 Q3	$2.65K	Buy	+110	New	+$2.3K	﹤0.01%	7046
2024 Q2	–	Sell	-177	Closed	-$3.79K	–	7512
2024 Q1	$3.79K	Sell	177 -83	-32%	-$1.56K	﹤0.01%	6215
2023 Q4	$3.97K	Sell	260 -89	-26%	-$1.58K	﹤0.01%	6256
2023 Q3	$8.05K	Sell	349 -489	-58%	-$11.2K	﹤0.01%	6048
2023 Q2	$19.9K	Buy	+838	New	+$19.2K	﹤0.01%	5569

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's INDV Position: Q2 2026 in Review

Osaic Holdings increased its Indivior Pharmaceuticals (INDV) stake by 36% in Q2 2026, buying an estimated $122K and bringing the position to 12,815 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

Osaic Holdings first reported a position in INDV in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.22M in Q4 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Osaic Holdings held 12,815 shares of Indivior Pharmaceuticals worth $526K as of Q2 2026.
Osaic Holdings bought 3,359 Indivior Pharmaceuticals shares in Q2 2026, an estimated $122K.
Indivior Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3630 holding.
Osaic Holdings first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
Osaic Holdings's Indivior Pharmaceuticals position peaked at $1.22M in Q4 2025.
336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.